vs
STANDARD BIOTOOLS INC.（LAB）与WINMARK CORP（WINA）财务数据对比。点击上方公司名可切换其他公司
WINMARK CORP的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$21.1M vs $19.6M），WINMARK CORP净利率更高（47.2% vs -177.4%，领先224.6%），WINMARK CORP同比增速更快（7.9% vs -11.5%），WINMARK CORP自由现金流更多（$8.5M vs $-23.1M），过去两年WINMARK CORP的营收复合增速更高（2.4% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
温马克公司是美国的二手商品零售特许经营商，总部位于明尼苏达州明尼阿波利斯，旗下运营五大零售品牌，专注于二手商品的收售业务。公司1988年由罗恩·奥尔森与杰弗里·达尔伯格创立，最初名为Play It Again Sports特许经营公司，1993年更名为Grow Biz国际并于同年上市。
LAB vs WINA — 直观对比
营收规模更大
WINA
是对方的1.1倍
$19.6M
营收增速更快
WINA
高出19.3%
-11.5%
净利率更高
WINA
高出224.6%
-177.4%
自由现金流更多
WINA
多$31.6M
$-23.1M
两年增速更快
WINA
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $21.1M |
| 净利润 | $-34.7M | $10.0M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 61.7% |
| 净利率 | -177.4% | 47.2% |
| 营收同比 | -11.5% | 7.9% |
| 净利润同比 | -28.8% | 3.9% |
| 每股收益（稀释后） | $-0.09 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABWINA
| Q4 25 | — | $21.1M | ||
| Q3 25 | $19.6M | $22.6M | ||
| Q2 25 | $21.8M | $20.4M | ||
| Q1 25 | $40.8M | $21.9M | ||
| Q4 24 | — | $19.5M | ||
| Q3 24 | $22.1M | $21.5M | ||
| Q2 24 | $22.5M | $20.1M | ||
| Q1 24 | $45.5M | $20.1M |
净利润LABWINA
| Q4 25 | — | $10.0M | ||
| Q3 25 | $-34.7M | $11.1M | ||
| Q2 25 | $-33.5M | $10.6M | ||
| Q1 25 | $-26.0M | $10.0M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $-26.9M | $11.1M | ||
| Q2 24 | $-45.7M | $10.4M | ||
| Q1 24 | $-32.2M | $8.8M |
毛利率LABWINA
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABWINA
| Q4 25 | — | 61.7% | ||
| Q3 25 | -168.5% | 65.9% | ||
| Q2 25 | -118.1% | 64.0% | ||
| Q1 25 | -80.8% | 62.0% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | -120.9% | 69.4% | ||
| Q2 24 | -134.5% | 64.7% | ||
| Q1 24 | -132.2% | 60.8% |
净利率LABWINA
| Q4 25 | — | 47.2% | ||
| Q3 25 | -177.4% | 49.2% | ||
| Q2 25 | -153.7% | 51.9% | ||
| Q1 25 | -63.8% | 45.4% | ||
| Q4 24 | — | 49.0% | ||
| Q3 24 | -122.0% | 51.7% | ||
| Q2 24 | -203.3% | 51.8% | ||
| Q1 24 | -70.6% | 43.9% |
每股收益（稀释后）LABWINA
| Q4 25 | — | $2.68 | ||
| Q3 25 | $-0.09 | $3.02 | ||
| Q2 25 | $-0.09 | $2.89 | ||
| Q1 25 | $-0.07 | $2.71 | ||
| Q4 24 | — | $2.60 | ||
| Q3 24 | $-0.07 | $3.03 | ||
| Q2 24 | $-0.12 | $2.85 | ||
| Q1 24 | $-0.27 | $2.41 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $-53.7M |
| 总资产 | $539.6M | $24.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABWINA
| Q4 25 | — | $10.3M | ||
| Q3 25 | $129.4M | $39.7M | ||
| Q2 25 | $158.6M | $28.8M | ||
| Q1 25 | $150.9M | $21.8M | ||
| Q4 24 | — | $12.2M | ||
| Q3 24 | $210.6M | $37.2M | ||
| Q2 24 | $269.8M | $29.4M | ||
| Q1 24 | $287.1M | $22.9M |
总债务LABWINA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABWINA
| Q4 25 | — | $-53.7M | ||
| Q3 25 | $399.7M | $-26.3M | ||
| Q2 25 | $424.5M | $-36.8M | ||
| Q1 25 | $454.6M | $-45.9M | ||
| Q4 24 | — | $-51.0M | ||
| Q3 24 | $489.3M | $-33.7M | ||
| Q2 24 | $510.3M | $-42.2M | ||
| Q1 24 | $577.3M | $-52.6M |
总资产LABWINA
| Q4 25 | — | $24.9M | ||
| Q3 25 | $539.6M | $53.7M | ||
| Q2 25 | $557.0M | $43.2M | ||
| Q1 25 | $579.6M | $37.1M | ||
| Q4 24 | — | $26.8M | ||
| Q3 24 | $681.5M | $52.0M | ||
| Q2 24 | $708.7M | $44.7M | ||
| Q1 24 | $777.7M | $38.3M |
负债/权益比LABWINA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $8.5M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $8.5M |
| 自由现金流率自由现金流/营收 | -118.1% | 40.3% |
| 资本支出强度资本支出/营收 | 4.5% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 0.86× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $44.7M |
8季度趋势，按日历期对齐
经营现金流LABWINA
| Q4 25 | — | $8.5M | ||
| Q3 25 | $-22.2M | $12.3M | ||
| Q2 25 | $-20.7M | $9.0M | ||
| Q1 25 | $-30.3M | $15.1M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | $-27.9M | $12.1M | ||
| Q2 24 | $-39.0M | $8.2M | ||
| Q1 24 | $-62.5M | $13.4M |
自由现金流LABWINA
| Q4 25 | — | $8.5M | ||
| Q3 25 | $-23.1M | $12.2M | ||
| Q2 25 | $-22.6M | $9.0M | ||
| Q1 25 | $-35.3M | $15.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | $12.1M | ||
| Q2 24 | $-41.0M | $8.1M | ||
| Q1 24 | $-63.3M | $13.3M |
自由现金流率LABWINA
| Q4 25 | — | 40.3% | ||
| Q3 25 | -118.1% | 53.8% | ||
| Q2 25 | -103.6% | 44.0% | ||
| Q1 25 | -86.6% | 68.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | 56.3% | ||
| Q2 24 | -182.2% | 40.4% | ||
| Q1 24 | -138.9% | 66.0% |
资本支出强度LABWINA
| Q4 25 | — | 0.1% | ||
| Q3 25 | 4.5% | 0.3% | ||
| Q2 25 | 8.7% | 0.3% | ||
| Q1 25 | 12.4% | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | 10.2% | 0.0% | ||
| Q2 24 | 8.6% | 0.5% | ||
| Q1 24 | 1.7% | 0.4% |
现金转化率LABWINA
| Q4 25 | — | 0.86× | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 1.51× | ||
| Q4 24 | — | 0.88× | ||
| Q3 24 | — | 1.09× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 1.52× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
WINA
暂无分部数据
